Proprietary AI analyst is now available
- Public Comps
- aXichem
aXichem Valuation Multiples
Discover revenue and EBITDA valuation multiples for aXichem and similar public comparables like Suntrade Group, Directa Plus, Plasticos Compuestos, Onesano and more.
aXichem Overview
About aXichem
aXichem AB develops and delivers nature-identical ingredients of the highest purity. The company offers axiphen-feed used in the breeding of chickens and pigs, Bio-repellents used to repel unwanted biological organisms from installations or areas, and aXivite an alternative to capsaicin.
Founded
1999
HQ

Employees
7
Website
Sectors
Financials (LTM)
EV
$10M
Valuation Multiples
Start free trialaXichem Financials
aXichem reported last 12-month revenue of $3M and negative EBITDA of ($940K).
In the same LTM period, aXichem generated ($940K) in EBITDA losses and had net loss of ($1M).
Revenue (LTM)
aXichem P&L
In the most recent fiscal year, aXichem reported revenue of $2M and EBITDA of ($1M).
aXichem is unprofitable as of last fiscal year, with gross margin of 47%, EBITDA margin of (66%), and net margin of (92%).
Financial data powered by Morningstar, Inc.
aXichem Stock Performance
aXichem has current market cap of $10M, and enterprise value of $10M.
Market Cap Evolution
aXichem's stock price is $0.15.
aXichem share price decreased by 6.1% in the last 30 days, and by 52.8% in the last year.
aXichem has an EPS (earnings per share) of $-0.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10M | $10M | 9.3% | -6.1% | -14.4% | -52.8% | $-0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialaXichem Valuation Multiples
aXichem trades at 3.8x EV/Revenue multiple, and (10.7x) EV/EBITDA.
EV / Revenue (LTM)
aXichem Financial Valuation Multiples
As of June 5, 2026, aXichem has market cap of $10M and EV of $10M.
aXichem has a P/E ratio of (6.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified aXichem Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


aXichem Margins & Growth Rates
aXichem grew revenue by 68% but EBITDA decreased by 75% in the last fiscal year.
In the most recent fiscal year, aXichem reported gross margin of 47%, EBITDA margin of (66%), and net margin of (92%).
aXichem Margins
aXichem Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
aXichem Operational KPIs
aXichem's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.4M for the same period.
aXichem's Rule of 40 is 65% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
aXichem's Rule of X is 176% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
aXichem Competitors
aXichem competitors include Suntrade Group, Directa Plus, Plasticos Compuestos, Onesano, Lordos United Public, Serstech, Berger Paints Jamaica, Encres Dubuit, Tribox Group and Sinteza.
Most aXichem public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 15.6x | - | (55.8x) | - | |||
| - | - | - | - | |||
| 0.3x | - | 3.9x | - | |||
| 3.6x | - | (10.5x) | - | |||
| 0.9x | - | 7.4x | - | |||
| 1.9x | - | (3.5x) | - | |||
| 0.3x | - | 4.5x | - | |||
| 0.2x | - | (2.7x) | - | |||
This data is available for Pro users. Sign up to see all aXichem competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout aXichem
| When was aXichem founded? | aXichem was founded in 1999. |
| Where is aXichem headquartered? | aXichem is headquartered in Sweden. |
| How many employees does aXichem have? | As of today, aXichem has over 7 employees. |
| Is aXichem publicly listed? | Yes, aXichem is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of aXichem? | aXichem trades under AXIC A ticker. |
| When did aXichem go public? | aXichem went public in 2011. |
| Who are competitors of aXichem? | aXichem main competitors include Suntrade Group, Directa Plus, Plasticos Compuestos, Onesano, Lordos United Public, Serstech, Berger Paints Jamaica, Encres Dubuit, Tribox Group, Sinteza. |
| What is the current market cap of aXichem? | aXichem's current market cap is $10M. |
| What is the current revenue of aXichem? | aXichem's last 12 months revenue is $3M. |
| What is the current revenue growth of aXichem? | aXichem revenue growth (NTM/LTM) is 119%. |
| What is the current EV/Revenue multiple of aXichem? | Current revenue multiple of aXichem is 3.8x. |
| Is aXichem profitable? | No, aXichem is not profitable. |
| What is the current EBITDA of aXichem? | aXichem has negative EBITDA and is not profitable. |
| What is aXichem's EBITDA margin? | aXichem's last 12 months EBITDA margin is (36%). |
| What is the current EV/EBITDA multiple of aXichem? | Current EBITDA multiple of aXichem is (10.7x). |
| How many companies aXichem has acquired to date? | aXichem hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies aXichem has invested to date? | aXichem hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to aXichem
Lists including aXichem
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.